# TIAZAC EXTENDED RELEASE

NDC: 0187-2616
Generic name: diltiazem hydrochloride
Labeler / Manufacturer: Bausch Health US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20140820

FDA application: NDA020401

## Active ingredients

- DILTIAZEM HYDROCHLORIDE: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-2616"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-2616
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c567fe7e-887e-4291-a0d1-2dd3f25cbf25